Creative Planning’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,878
| Closed | -$14K | – | 2382 |
|
|
2022
Q3 | $14K | Buy |
+12,878
| New | +$14K | ﹤0.01% | 2160 |
|
|
2019
Q3 | – | Sell |
-101,698
| Closed | -$409K | – | 1869 |
|
|
2019
Q2 | $409K | Hold |
101,698
| – | – | ﹤0.01% | 1178 |
|
|
2019
Q1 | $437K | Sell |
101,698
-20,000
| -16% | -$85.9K | ﹤0.01% | 1104 |
|
|
2018
Q4 | $700K | Buy |
121,698
+798
| +0.7% | +$4.59K | ﹤0.01% | 805 |
|
|
2018
Q3 | $1.64M | Buy |
120,900
+18,000
| +17% | +$244K | 0.01% | 536 |
|
|
2018
Q2 | $1.22M | Buy |
102,900
+4,000
| +4% | +$47.5K | ﹤0.01% | 636 |
|
|
2018
Q1 | $1.11M | Buy |
98,900
+32,219
| +48% | +$362K | ﹤0.01% | 674 |
|
|
2017
Q4 | $445K | Buy |
66,681
+26,681
| +67% | +$178K | ﹤0.01% | 1137 |
|
|
2017
Q3 | $328K | Sell |
40,000
-500
| -1% | -$4.1K | ﹤0.01% | 1263 |
|
|
2017
Q2 | $182K | Hold |
40,500
| – | – | ﹤0.01% | 1561 |
|
|
2017
Q1 | $223K | Buy |
40,500
+10,000
| +33% | +$55.1K | ﹤0.01% | 1411 |
|
|
2016
Q4 | $124K | Buy |
30,500
+1,000
| +3% | +$4.07K | ﹤0.01% | 1700 |
|
|
2016
Q3 | $208K | Hold |
29,500
| – | – | ﹤0.01% | 1375 |
|
|
2016
Q2 | $240K | Sell |
29,500
-3,000
| -9% | -$24.4K | ﹤0.01% | 1161 |
|
|
2016
Q1 | $264K | Buy |
32,500
+9,950
| +44% | +$80.8K | ﹤0.01% | 1070 |
|
|
2015
Q4 | $272K | Buy |
22,550
+12,050
| +115% | +$145K | ﹤0.01% | 1034 |
|
|
2015
Q3 | $126K | Buy |
+10,500
| New | +$126K | ﹤0.01% | 1446 |
|